Cardiovascular Diagnostic Testing Market To Reach $ 15.43 Billion Globally By 2030 At 8.3% CAGR: Allied Market Research


The increase in medical technological innovations, the initiatives to educate patients and the increase in the geriatric population along with the increase in the prevalence of cardiovascular diseases have driven the growth of the global cardiovascular diagnostic tests market.

PORTLAND, Ore., December 16, 2021 / PRNewswire / – Allied Market Research recently released a report titled, Cardiovascular Diagnostic Tests Market by type (laboratory developed tests and in vitro diagnostic tests), panel (atherosclerotic cardiovascular disease risk panel with score) and end user (laboratory testing facilities, academic institutes and point-of-care testing facilities) : Analysis of Global Opportunities and Industry Forecast, 2021-2030 “. According to the report, the global cardiovascular diagnostic testing industry has generated $ 6.87 billion in 2020, and is expected to reach $ 15.43 billion by 2030, with a CAGR of 8.3% from 2021 to 2030.

AMR logo

Download Sample Report – https://www.alliedmarketresearch.com/request-sample/14656

Main determinants of market growth

The increase in medical technological innovations, the initiatives to educate patients and the increase in the geriatric population along with the increase in the prevalence of cardiovascular diseases have driven the growth of the global cardiovascular diagnostic tests market. However, changes in FDA regulations and LDT guidelines, along with limited insurance coverage and the high cost of devices are hampering market growth. On the contrary, the development of health infrastructure in emerging countries should open up new opportunities for market players in the future.

Covid-19 scenario:

  • The Covid-19 pandemic is having a positive impact on the market because the Covid-19 infection has severe imprecations in the cardiovascular system.

  • The Covid-19 pandemic can promote several cardiovascular disorders such as arrhythmias, myocardial damage and acute coronary syndrome.

  • The Covid-19 pandemic has highlighted the importance of reliable diagnostic tests and the rapid development of new tests.

Get Detailed Impact Analysis Of COVID-19 In Cardiovascular Diagnostic Testing Market https://www.alliedmarketresearch.com/request-for-customization/14656?reqfor=covid

In vitro diagnostic testing segment dominated the market

By type, in vitro diagnostic segment held the largest share in 2020, accounting for over 90% of the global cardiovascular diagnostic assay market, due to increasing demand for non-invasive diagnostic techniques and technological advancements. allowing the replacement of old conventional devices. with new ones. However, the lab-grown test segment is expected to post the highest CAGR of 11.2% during the forecast period, as it offers accurate and quality testing for several cardiovascular diseases.

The segment of point-of-service testing facilities to represent the highest CAGR until 2030

By end-user, the point-of-care testing facilities segment is expected to represent the highest CAGR of 8.7% during the forecast period as it enables rapid detection of analytes near the patient, which facilitates rapid medical decisions and better diagnosis, management, and monitoring. However, the laboratory testing facilities segment held the largest share in 2020, contributing more than two-fifths of the global cardiovascular diagnostic testing market, due to the increase in the prevalence of cardiovascular disease and the increase in cardiovascular disease prevalence. demand for laboratory tests.

For Purchase Inquiry – https://www.alliedmarketresearch.com/purchase-enquiry/14656

North America held the lion’s share

By Region, The Global Cardiovascular Diagnostic Tests Market Across North America dominated the market in 2020, accounting for more than two-fifths of the market, due to the high prevalence of cardiovascular disease, increased awareness of various heart diseases, and the presence of a large number of domestic diagnostic machine manufacturers in vitro. However, the market through Asia Pacific is expected to register the highest CAGR of 9.4% during the forecast period, due to high per capita income, improved health infrastructure and increased disposable income.

Major market players

  • Abbott Laboratories

  • bioMérieux, Inc.

  • Becton, Dickinson and company

  • Bio-Rad Laboratories, Inc.

  • F. Hoffmann-La Roche Ltée

  • Danaher Company

  • PerkinElmer, Inc.

  • Thermo Fisher Scientific, Inc.

  • Siemens AG

  • Tosoh Company

Official press release: https://www.alliedmarketresearch.com/press-release/cardiovascular-diagnostic-testing-market.html

Similar research reports for information, communication and technology:

Paclitaxel Eluting Stents Market Global Opportunity Analysis and Industry Forecast 2021-2030

Hysteroscope Market Global Opportunity Analysis and Industry Forecast 2021-2030

Interventional Oncology Market – Global Opportunity Analysis and Industry Forecast, 2021-2030

Intraosseous Infusion Devices Market – Global Opportunity Analysis and Industry Forecast, 2021-2030

Orthopedic Consumables Market – Global Opportunity Analysis and Industry Forecast, 2021-2030

AVENUE – A subscription-based library (Premium on-demand, subscription-based pricing model):

AMR presents its premium online subscription-based Avenue library, designed specifically to provide a unique and cost-effective solution for businesses, investors and universities. With Avenue, subscribers can benefit from a comprehensive repository of reports on over 2,000 niche industries and over 12,000 company profiles. Additionally, users can get online access to quantitative and qualitative data in PDF and Excel formats as well as analyst support, customization and updated versions of reports.

Access the report library anytime from any device and anywhere. For more details follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a market research and business consulting division of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global businesses as well as medium and small businesses with unmatched quality of “market research reports” and “business intelligence solutions”. AMR has a focused vision to provide business information and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market areas. AMR offers its services in 11 verticals, including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverage, Energy & Electricity, semiconductors and electronics, automotive and transportation, ICT and media, aerospace and defense and BFSI.

We have professional relationships with various companies, which helps us extract market data which helps us generate accurate research data tables and confirm the highest accuracy in our market forecast. CEO of Allied Market Research Pawan kumar is essential in inspiring and encouraging everyone associated with the business to maintain high quality data and to help customers in every way possible to be successful. Each of the data presented in the reports we publish is taken from primary interviews with senior officials of the main companies in the field concerned. Our secondary data sourcing methodology includes in-depth online and offline research and discussions with industry-savvy professionals and analysts.

Contact:

David Corréa
5933 NE Win Sivers Drive
# 205, Portland, OR 97220
United States
Toll Free: + 1-800-792-5285
UK: + 44-845-528-1300
Hong Kong: + 852-301-84916
India (Pune): + 91-20-66346060
Fax: + 1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com
Follow us on: LinkedIn Twitter

Cision

Cision

View original content: https://www.prnewswire.com/news-releases/cardiovascular-diagnostic-testing-market-to-reach-15-43-bn-globally-by-2030-at-8-3-cagr – allied-market-research-301445418.html

SOURCE Allied market research



Comments are closed.